Extremely low dose of 6-mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations.
Xiao-Ying ZhaiYue ZhouLei DongAi-Qing NieLi-Juan ZhiEvelyne Jacqz-AigrainTian-You WangLi WangWei ZhaoPublished in: Journal of clinical pharmacy and therapeutics (2020)
Complex pharmacogenetic tests and TDM should be recommended in children with complicated ALL to highlight the large individual variability in the responses to 6-MP exposure and the associated adverse effects.